Medical devices, healthcare technology and the business of care
510(k) clearance · K253195

TAURUS Posterior Occipital-Cervico-Thoracic Spinal Systems

ZheJiang Decans Medical Devices Co., Ltd. · Decision date Jun 2, 2026

FDA DECISIONK253195

What did the FDA decide?

FDA records K253195 as a 510(k) premarket notification, with a decision dated Jun 2, 2026. The decision code SESE records a finding of substantial equivalence. This is a 510(k) clearance.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Orthopedic
Decision date
Jun 2, 2026

FDA source record

Regulatory record facts

Identifier
K253195
Regulatory pathway
510(k) premarket notification
Product code
NKG
Decision code
SESE
Decision date
Jun 2, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Posterior Cervical Screw System.

Product code
NKG
FDA device class
2

FDA decision timeline

  1. K253195 received

    Application receipt date recorded by FDA.

  2. K253195 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code NKG

Product / regulatory recordCompanyPathwayDecision dateSource
GS Medical Co., Ltd.510(k) clearanceSep 17, 2026FDA
CARBOFIX ORTHOPEDICS LTD510(k) clearanceMar 16, 2026FDA
MEDTRONIC SOFAMOR DANEK USA, INC.510(k) clearanceJan 21, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

ZheJiang Decans Medical Devices Co., Ltd.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Jiaxing

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records